President Donald Trump announced a new government website that will allow Americans to purchase medications directly from pharmaceutical companies, including Pfizer. The White House is calling it “TrumpRx.”
The CEO of Pfizer, Albert Bourla, appeared alongside the president, Health Secretary Robert F. Kennedy Jr. and Mehmet Oz, Administrator of the Centers for Medicare and Medicaid Services, to make the announcement Tuesday.
In addition to working with the administration on TrumpRx, Pfizer will also offer all of its medications to Medicaid at reduced prices, offer some popular medications to all patients at discounted prices, offer new drugs at prices that match those paid by other developed nations and invest $70 billion in domestic manufacturing and research and development, Trump said.
“We’re working with other major pharmaceutical companies to secure similar agreements,” Trump said.
Trending
Trump gave drugmakers a Sept. 29 deadline to respond to his executive order “Reducing Drug Prices for Americans and Taxpayers,” which called for companies to acquiesce to his “Most Favored Nation” pricing plan. That plan calls for aligning U.S. drug prices with prices offered to other developed countries.
Pharmaceutical companies have been scrambling to respond to the executive order and to Trump’s demands of industry leaders to offer most-favored-nation pricing for all new drugs, as well as to Medicaid. Trump has said the pharmaceutical industry should reinvest the revenue from selling drugs abroad in American manufacturing.
Trump announced a 100% tariff on pharmaceutical products made by companies that are not building pharmaceutical manufacturing plants in the U.S. last week. Pfizer’s new investment would seemingly exempt it from this tariff.
“If you move here, there are no tariffs,” Trump said.
The drug pricing executive order called for manufacturers to sell drugs directly to consumers — which TrumpRx will now do. A senior administration official told reporters after the press conference that the website is scheduled to be live in early 2026.
The pharmaceutical industry lobbying group PhRMA also announced a new website Monday that will compile drug makers’ direct-to-consumer offerings. That website, Americasmedicines.com, will be launched in Jan. 2026, the group said.
Having the government play a bigger role in bringing down drug prices has long been advocated for — but most commonly from the left. The Democratic billionaire Mark Cuban’s website Cost Plus Drugs offers a similar model to TrumpRx and has grown rapidly in recent years.
“This is something Democrats have wanted for 20 years. Republicans have wanted for 20 years,” Kennedy said during the press conference. “Everyone has said they’re going to do it. Nobody has even taken a step towards doing it. And the reason was because it was such a daunting task.”
Author
